Literature DB >> 10820371

Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1alpha.

I Angulo1, J Rullas, J A Campillo, E Obregón, A Heath, M Howard, M A Muñoz-Fernández, J L Subiza.   

Abstract

Bone marrow contains nonadherent low-density wheat germ agglutinin-positive (Fr3-WGA(+)) cells that release large amounts of NO and show natural suppressor activity if stimulated with activated T cells. We have assessed the involvement of CD40-derived signals in NO production and their cytokine requirements. Production of NO by Fr3-WGA(+) cells in co-culture with activated T cells is inhibited by a competing CD40 soluble fusion protein. Fr3-WGA(+) cells express the inducible NO synthase (iNOS) and release NO following CD40 plus IFN-gamma activation. Production of NO through CD40 is strictly dependent on endogenous TNF-alpha and / or IL-1alpha, since it is inhibited by neutralizing these cytokines or blocking the TNF receptor (p55). Both cytokines are transcribed when Fr3-WGA(+) cells are stimulated by CD40 signaling plus IFN-gamma, although TNF-alpha remains below detection limits in stimulated Fr3-WGA(+) cell cultures. Phenotypic studies combined with data on intracellular iNOS expression and cell sorting indicate that NO-producing cells are CD40, CD31 (ER-MP12), CD11b (Mac-1)low, ER-MP20 (Ly-6C) and Gr-1 (Ly-6G) positive, consistent with myeloid progenitors. The results point to early myeloid cells as an important cell source of NO once triggered by activated T cells through CD40 and IFN-gamma-derived signals, in a mechanism involving the production of TNF-alpha and / or IL-1alpha.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820371     DOI: 10.1002/(SICI)1521-4141(200005)30:5<1263::AID-IMMU1263>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer.

Authors:  Sabrin Husein Albeituni; Chuanlin Ding; Jun Yan
Journal:  Cancer J       Date:  2013 Nov-Dec       Impact factor: 3.360

Review 2.  Myeloid-derived suppressor cells: a double-edged sword?

Authors:  Agnieszka Pastuła; Janusz Marcinkiewicz
Journal:  Int J Exp Pathol       Date:  2011-02-12       Impact factor: 1.925

3.  Tumor-associated neutrophils induce apoptosis of non-activated CD8 T-cells in a TNFα and NO-dependent mechanism, promoting a tumor-supportive environment.

Authors:  Janna Michaeli; Merav E Shaul; Inbal Mishalian; Avi-Hai Hovav; Liran Levy; Lidia Zolotriov; Zvi Granot; Zvi G Fridlender
Journal:  Oncoimmunology       Date:  2017-08-16       Impact factor: 8.110

4.  TNFR1 signalling is a critical checkpoint for developing macrophages that control of T-cell proliferation.

Authors:  Ben J E Raveney; David A Copland; Claudia J Calder; Andrew D Dick; Lindsay B Nicholson
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

5.  The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.

Authors:  Junko Ozao-Choy; Ge Ma; Johnny Kao; George X Wang; Marcia Meseck; Max Sung; Myron Schwartz; Celia M Divino; Ping-Ying Pan; Shu-Hsia Chen
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

6.  Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.

Authors:  Ping-Ying Pan; George X Wang; Bingjiao Yin; Junko Ozao; Teresa Ku; Celia M Divino; Shu-Hsia Chen
Journal:  Blood       Date:  2007-09-20       Impact factor: 22.113

7.  Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.

Authors:  Ping-Chih Ho; Katrina M Meeth; Yao-Chen Tsui; Bhaskar Srivastava; Marcus W Bosenberg; Susan M Kaech
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701

8.  Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity.

Authors:  Johannes Polz; Annika Remke; Sabine Weber; Dominic Schmidt; Dorothea Weber-Steffens; Anne Pietryga-Krieger; Nils Müller; Uwe Ritter; Sven Mostböck; Daniela N Männel
Journal:  Immun Inflamm Dis       Date:  2014-05-28

9.  Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections.

Authors:  Takayuki Matsumura; Manabu Ato; Tadayoshi Ikebe; Makoto Ohnishi; Haruo Watanabe; Kazuo Kobayashi
Journal:  Nat Commun       Date:  2012-02-14       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.